Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study

Atherosclerosis

Volumn 225, Issue 2, 2012, Pages 408-411

  Parrinello, Christina M ^a   Landay, Alan L ^b   Hodis, Howard N ^c   Gange, Stephen J ^d   Norris, Philip J ^e,f   Young, Mary ^g   Anastos, Kathryn ^a   Tien, Phyllis C ^f,h   Xue, Xiaonan ^a   Lazar, Jason ⁱ   Benning, Lorie ^d   Tracy, Russell P ^j   Kaplan, Robert C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^h SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ SUNY DOWNSTATE MEDICAL CENTER   (United States)

^j UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Cardiovascular diseases; Carotid arteries; HAART; HIV; Lipids

Indexed keywords

ANTIRETROVIRUS AGENT; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ARTERY DIAMETER; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASYMPTOMATIC DISEASES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; HYPERLIPIDEMIAS; LINEAR MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84869498025     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.09.035     Document Type: Article

References (15)

1. Rose H., Hoy J., Woolley I., et al. HIV infection and high density lipoprotein metabolism. Atherosclerosis 2008, 199:79-86.
2. Anastos K., Lu D., Shi Q., et al. Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. J Acquir Immune Defic Syndr 2007, 45:34-42.
3. Asztalos B.F., Schaefer E.J., Horvath K.V., et al. Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients. Atherosclerosis 2006, 184:72-77.
4. Riddler S.A., Smit E., Cole S.R., et al. Impact of HIV infection and HAART on serum lipids in men. J Am Med Assoc 2003, 289:2978-2982.
5. Young J., Weber R., Rickenbach M., et al. Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study. Antivir Ther 2005, 10:585-591.
6. Grover S.A., Coupal L., Gilmore N., Mukherjee J. Impact of dyslipidemia associated with highly active antiretroviral therapy (HAART) on cardiovascular risk and life expectancy. Am J Cardiol 2005, 95:586-591.
7. Almeida S.E., Borges M., Fiegenbaum M., Nunes C.C., Rossetti M.L. Metabolic changes associated with antiretroviral therapy in HIV-positive patients. Rev Saude Publica 2009, 43:283-290.
8. Riddler S.A., Li X., Chu H., et al. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy. HIV Med 2007, 8:280-287.
9. Herder M., Johnsen S.H., Arntzen K.A., Mathiesen E.B. Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromso study. Stroke 2012, 43:1818-1823.
10. Kwiatkowska W., Knysz B., Drelichowska-Durawa J., et al. Subclinical carotid atherosclerosis and cardiovascular risk factors in HIV-infected patients. Postepy Hig Med Dosw 2011, 65:770-783. Online.
11. Badiou S., Thiebaut R., Aurillac-Lavignolle V., et al. Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients. J Infect 2008, 57:47-54.
12. Kaplan R.C., Kingsley L.A., Gange S.J., et al. Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 2008, 22:1615-1624.
13. Hsue P.Y., Lo J.C., Franklin A., et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004, 109:1603-1608.
14. Hodis H.N., Mack W.J., Lobo R.A., et al. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001, 135:939-953.
15. Kaplan R.C., Landay A.L., Hodis H.N., et al. Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment. J Acquir Immune Defic Syndr 2012, 60:359-368.